Skip to main content

Table 2 Demographic and clinical characteristics of study subjects

From: Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia

  Total Male Female
Number of subjects, n (%) 200 129(64.5) 71(35.5)
Age (in years) mean ± SD 38.4 ± 9.8 38.4 ± 10.1 38.4 ± 9.4
Waist circumference in cm mean ± SD 89.3 ± 9.7 88.4 ± 8.7 91 ± 11
BMI (Kg/m2) ≥ 25 n (%) 73(36.5) 32(24.8) 41(57.7)
Ethnicity n (%)
 Amhara 82(41.0) 48(37.2) 34(47.9)
 Oromo 45(22.5) 30(23.3) 15(21.1)
 Tigray 8(4.0) 5(3.9) 3(4.2)
 Gurage 42(21.0) 28(21.7) 14(19.7)
 others 23(11.5) 18(14.0) 5(7.0)
Systolic Blood pressure (mm Hg) mean ± SD 120 ± 18 121 ± 17 118 ± 21
Diastolic Blood Pressure (mm Hg) mean ± SD 78.4 ± 11.5 78.7 ± 11.7 78.0 ± 11.1
Pharmacological treatment n (%)
 FGAs 132(66.3) 88(68.8) 44(62.0)
 SGAs 67(33.7) 40(31.2) 27(38.0)
Lives with parental family n (%) 160(80.0) 112(86.8) 48(67.6)
PANSS Score mean ± SD 83.6 ± 15.4 84.0 ± 15.4 82.9 ± 15.6
Smokers n (%) 42(21.4) 41(32.5) 1(1.4)
Khat chewing Status n (%)
 Yes 16(8.2) 16(12.7) 0(0)
 No 180(91.8) 110(87.3) 70(100)
Occupational Status, working n (%) 44(22.0) 29(22.5) 15(21.1)
Duration of illness (Years), mean ± SD 14 ± 9 15 ± 9 14 ± 9
Marital Status, Married n (%) 28(14.0) 15(11.6) 13(18.3)
Total Cholesterol (mg/dl), median (IQR) 183(216–157) 176(211–154) 198(221–174)
Triglycerides (mg/dl), median (IQR) 118(164–83) 123(179–87) 103(149–77)
HDL-Cholesterol (mg/dl), median (IQR) 45(54–38) 43(49–36) 50(60–44)
FBG(mg/dl), median (IQR) 91(100–86) 91(98–86) 91(103–86)
  1. Abbreviations: COR Crude odds ratios, SD standard deviation, BMI Body mass index, WC Waist Circumference, BP blood pressure, PANSS Positive and Negative Syndrome Scale, FGAs first generation antipsychotics, SGAs second generation antipsychotics, HDL high-density lipoprotein, FBG Fasting blood glucose, IQR interquartile range